FDA Inspection 1089898 — Daicel Chiral Technologies (India) Private Limited
The FDA completed an inspection of Daicel Chiral Technologies (India) Private Limited on March 26, 2019 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 26, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hyderabad (India)
Additional Details
Bioanalytical BA/BE